The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.

Authors : Di Cosimo S, Triulzi T, Pizzamiglio S, De Cecco L, de Azambuja E, Fumagalli D, Putzai L, Harbeck N, Izquierdo M, Peña L, Daidone MG, Huober J, Gori S, Cinieri S, Torri V, Baselga J, Piccart-Gebhart M, De Braud FG, Apolone G, Verderio P, Tagliabue E
Year : 2019
Journal : Eur J Cancer
Volume : 118
Pages : 1-9